Company Overview
Snapshot
Founded in September 2016 by Yenon Vashdi, Kaneh Bosem operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on research and development.
Business overview
Kaneh Bosem is a startup in the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology and Medical Cannabis. The company is dedicated to expanding the therapeutic potential of cannabis by leveraging the entourage effect, which combines the main cannabinoids THC and CBD with other naturally occurring compounds like terpenes and flavonoids. Kaneh Bosem develops specific growing protocols and processing methods to create unique wide-spectrum organic cannabis extracts, validated through lab tests and analysis. It serves both B2B and B2C markets, targeting consumers and the broader healthcare and life sciences industries, including biotechnology and pharmaceuticals.
Log in to access full profile ›Company Intelligence Q&A
- When was Kaneh Bosem founded?
- Kaneh Bosem was founded in September 2016 by Yenon Vashdi.
- What is Kaneh Bosem's primary focus?
- Kaneh Bosem focuses on expanding the therapeutic potential of cannabis by utilizing the entourage effect, combining various cannabis compounds to create unique wide-spectrum formulas of organic cannabis extracts.
- What stage is Kaneh Bosem currently in?
- Kaneh Bosem is currently in the Pre-Funding stage, with its product development in the R&D phase.
- What markets does Kaneh Bosem target?
- Kaneh Bosem targets both B2B and B2C markets, including recreational and lifestyle consumers, as well as the biotechnology and pharmaceutical sectors.
- What is the status of Kaneh Bosem?
- Kaneh Bosem has been Non Active since October 2018.